Homocysteine potentiates seizures and cell loss induced by pilocarpine treatment

NeuroMolecular Medicine

Volumn 12, Issue 3, 2010, Pages 248-259

  Baldelli, Enrica ^a   Leo, Giuseppina ^a   Andreoli, Nicola ^a   Fuxe, Kjell ^b   Biagini, Giuseppe ^a   Agnati, Luigi F ^a,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c IRRCS San Camillo Lido   (Italy)

Author keywords

Allosteric modulation; Amyloid beta Entorhinal cortex; Epilepsy; Hippocampus; Homocysteine; Neurodegeneration; Pilocarpine; Subiculum

Indexed keywords

AMYLOID BETA PROTEIN; HOMOCYSTEINE; PILOCARPINE; SODIUM CHLORIDE; TOLONIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL LOSS; CONTROLLED STUDY; DRUG ANTAGONISM; EPILEPTIC STATE; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; MALE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; TEMPORAL LOBE EPILEPSY;

AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; HOMOCYSTEINE; HUMANS; MALE; NERVE DEGENERATION; ORGANIC CHEMICALS; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

ANIMALIA; HEDYOTIS MANNII; RATTUS; RODENTIA;

EID: 78649972918     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8110-1     Document Type: Article

References (56)

1. Agnati, L. F., Ferré, S., Genedani, S., Leo, G., Guidolin, D., Filaferro, M., et al. (2006). Allosteric modulation of dopamine D2 receptors by homocysteine. Journal of Proteome Research, 5, 3077-3083.
2. Agnati, L. F., Genedani, S., Leo, G., Forni, A., Woods, A. S., Filaferro, M., et al. (2007). Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. Journal of Neural Transmission, 114, 21-31.
3. Agnati, L. F., Leo, G., Genedani, S., Andreoli, N., Marcellino, D., Woods, A., et al. (2008). Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains. Brain Research Reviews, 58, 459-474.
4. Agnati, L. F., Leo, G., Vergoni, A. V., Martinez, E., Hockemeyer, J., Lluis, C., et al. (2004). Neuroprotective effect of L-DOPA coadministered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease. Brain Research Bulletin, 64, 155-164.
5. Avoli, M., D'Antuono, M., Louvel, J., Kohling, R., Biagini, G., Pumain, R., et al. (2002). Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system. Progress in Neurobiology, 68, 167-207.
6. Belcastro, V., Gaetano, G., Italiano, D., Oteri, G., Caccamo, D., Pisani, L. R., et al. (2007). Antiepileptic drugs and MTHFR polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients. Epilepsia, 48, 1990-1994.
7. Bernasconi, A., Martinez, V., Rosa-Neto, P., D'Agostino, D., Bernasconi, N., Berkovic, S., et al. (2001). Surgical resection for intractable epilepsy in ''double cortex'' syndrome yields inadequate results. Epilepsia, 2, 1124-1129.
8. Biagini, G., Avoli, M., Marcinkiewicz, J., & Marcinkiewicz, M. (2001). Brain-derived neurotrophic factor superinduction parallels anti-epileptic-neuroprotective treatment in the pilocarpine epilepsy model. Journal of Neurochemistry, 76, 1814-1822.
9. Biagini, G., Baldelli, E., Longo, D., Contri, M. B., Guerrini, U., Sironi, L., et al. (2008). Proepileptic influence of a focal vascular lesion affecting entorhinal cortex-CA3 connections after status epilepticus. Journal of Neuropathology and Experimental Neurology, 67, 687-701.
10. Biagini, G., Baldelli, E., Longo, D., Pradelli, L., Zini, I., Rogawski, M. A., et al. (2006). Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Experimental Neurology, 201, 519-524. (Pubitemid 44344227)
11. Biagini, G., D'Arcangelo, G., Baldelli, E., D'Antuono, M., Tancredi, V., & Avoli, M. (2005). Impaired activation of CA3 pyramidal neurons in the epileptic hippocampus. Neuromolecular Medicine, 7, 325-342.
12. Bo, P., Soragna, D., Marchioni, E., Candeloro, E., Albergati, A., & Savoldi, F. (1995). Role of dopamine D-1 and D-2 antagonists in a model of focal epilepsy induced by electrical stimulation of hippocampus and amygdala in the rabbit. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 19, 917-930.
13. Bozzi, Y., & Borrelli, E. (2006). Dopamine in neurotoxicity and neuroprotection: What do D2 receptors have to do with it? Trends in Neurosciences, 29, 167-174.
14. Bozzi, Y., Vallone, D., & Borrelli, E. (2000). Neuroprotective role of dopamine against hippocampal cell death. Journal of Neuroscience, 20, 8643-8649.
15. Caccamo, D., Condello, S., Gorgone, G., Crisafulli, G., Belcastro, V., Gennaro, S., et al. (2004). Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. Neuromolecular Medicine, 6, 117-126.
16. Curia, G., Longo, D., Biagini, G., Jones, R. S., & Avoli, M. (2008). The pilocarpine model of temporal lobe epilepsy. Journal of Neuroscience Methods, 172, 143-157.
17. Du, F., Eid, T., Lothman, E. W., Kohler, C., & Schwarcz, R. (1995). Preferential neuronal loss in layer III of the medial entorhinal cortex in rat models of temporal lobe epilepsy. Journal of Neuroscience, 15, 6301-6313.
18. Folbergrová, J., Druga, R., Otahal, J., Haugvicová, R., Mares, P., & Kubova, H. (2006). Effect of free radical spin trap N-tert-butyl- ©-phenylnitrone (PBN) on seizures induced in immature rats by homocysteic acid. Experimental Neurology, 201, 105-119.
19. Freitas, R. M., Vasconcelos, S. M., Souza, F. C., Viana, G. S., & Fonteles, M. M. (2005). Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats. The FEBS Journal, 272, 1307-1312.
20. Fuerst, D., Shah, J., Shah, A., & Watson, C. (2003). Hippocampal sclerosis is a progressive disorder: A longitudinal volumetric MRI study. Annals of Neurology, 53, 413-116.
21. Fujikawa, D. G. (1996). The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Research, 725, 11-22.
22. Fuxe, K., Härfstrand, A., Agnati, L. F., Yu, Z. Y., Cintra, A., Wikström, A. C., et al. (1985). Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor. Neuroscience Letters, 60, 1-6.
23. Gorgone, G., Caccamo, D., Pisani, L. R., Currò, M., Parisi, G., Oteri, G., et al. (2009). Hyperhomocysteinemia in patients with epilepsy: Does it play a role in the pathogenesis of brain atrophy? A preliminary report. Epilepsia, 50(Suppl 1), 33-36.
24. Grieve, A., Butcher, S. P., & Griffiths, R. (1992). Synaptosomal plasma membrane transport of excitatory sulphur amino acid transmitter candidates: Kinetic characterisation and analysis of carrier specificity. Journal of Neuroscience Research, 32, 60-68.
25. Honer, W. G., Beach, T. G., Hu, L., Berry, K., Dorovini-Zis, K., Moore, G. R., et al. (1994). Hippocampal synaptic pathology in patients with temporal lobe epilepsy. Acta Neuropathologica, 87, 202-210.
26. Kruman, I. I., Culmsee, C., Chan, S. L., Kruman, Y., Guo, Z., Penix, L., et al. (2000). Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. Journal of Neuroscience, 20, 6920-6926.
27. LaFerla, F. M., Green, K. N., & Oddo, S. (2007). Intracellular amyloid-bold beta in Alzheimer's disease. Nature Reviews Neuroscience, 8, 499-509.
28. Leo, G., Genedani, S., Filaferro, M., Carone, C., Andreoli, N., Astancolle, S., et al. (2007). Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides. Current Alzheimer Research, 4, 305-313.
29. Lipton, S. A., Kim, W. K., Choi, Y. B., Kumar, S., D'Emilia, D. M., Rayudu, P. V., et al. (1997). Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proceedings of the National Academy of Sciences of the United States of America, 94, 5923-5928.
30. Liu, Z., Nagao, T., Desjardins, C. G., Gloor, P., & Avoli, M. (1994). Quantitative evaluation of neuronal loss in the dorsal hippocampus in rats with long term pilocarpine seizures. Epilepsy Research, 17, 237-247.
31. Marangos, P. J., Loftus, T., Wiesner, J., Lowe, T., Rossi, E., Browne, C. E., et al. (1990). Adenosinergic modulation of homocysteine-induced seizures in mice. Epilepsia, 31, 239-246.
32. Mares, P., Folbergrová, J., Langmeier, M., Haugvicová, R., & Kubová, H. (1997). Convulsant action of D, L-homocysteic acid and its stereoisomers in immature rats. Epilepsia, 38, 767-776.
33. Martignoni, E., Tassorelli, C., Nappi, G., Zangaglia, R., Pacchetti, C., & Blandini, F. (2007). Homocysteine and Parkinson's disease: A dangerous liaison? Journal of the Neurological Sciences, 257, 31-37.
34. Mathern, G. W., Kuhlman, P. A., Mendoza, D., & Pretorius, J. K. (1997). Human fascia dentata anatomy and hippocampal neuron densities differ depending on the epileptic syndrome and age at first seizure. Journal of Neuropathology and Experimental Neurology, 56, 199-212.
35. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., et al. (2000). High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. Journal of Neuroscience, 20, 4050-4058.
36. Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B., Pyeritz, R. E., et al. (1985). The natural history of homocystinuria due to cystathionine beta-synthase deficiency. American Journal of Human Genetics, 37, 1-31.
37. Navarro Mora, G., Bramanti, P., Osculati, F., Chakir, A., Nicolato, E., Marzola, P., et al. (2009). Does pilocarpine-induced epilepsy in adult rats require status epilepticus? Plos One, 4, e5759.
38. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., et al. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. Journal of Neuroscience, 26, 10129-10140.
39. Obeid, R., & Herrmann, W. (2009). Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Letters, 583, 1215-1225.
40. Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., et al. (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron, 55, 697-711.
41. Paxinos, G., & Watson, C. (1998). The rat brain in stereotaxic coordinates (4th ed.). San Diego: Academic.
42. Pitkanen, A., & Sutula, T. P. (2002). Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporallobe epilepsy. Lancet Neurology, 1, 173-181.
43. Racine, R. J., Gartner, J. G., & Burnham, W. M. (1972). Epileptiform activity and neural plasticity in limbic structures. Brain Research, 47, 262-268.
44. Schmidt-Kastner, R., Heim, C., & Sontag, K. H. (1991). Damage of substantia nigra pars reticulata during pilocarpine-induced status epilepticus in the rat: Immunohistochemical study of neurons, astrocytes and serum-protein extravasation. Experimental Brain Research, 86, 125-140.
45. Schmued, L. C., Albertson, C., & Slikker, W., Jr. (1997). Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochem- ical localization of neuronal degeneration. Brain Research, 751, 37-46.
46. Schwaninger, M., Ringleb, P., Winter, R., Kohl, B., Fiehn, W., Rieser, P. A., et al. (1999). Elevated plasma concentrations of homo-cysteine in antiepileptic drug treatment. Epilepsia, 40, 345-350.
47. Selhub, J. (2008). Public health significance of elevated homocysteine. Food and Nutrition Bulletin, 29(Suppl 2), S116-S125.
48. Smolders, I., Khan, G. M., Manil, J., Ebinger, G., & Michotte, Y. (1997). NMDA receptor-mediated pilocarpine-induced seizures: Characterization in freely moving rats by microdialysis. British Journal of Pharmacology, 121, 1171-1179. (Pubitemid 27303587)
49. Spencer, S. (2002). Neural networks in human epilepsy: Evidence of and implications for treatment. Epilepsia, 43, 219-227.
50. Sternberger, L. A., & Sternberger, N. H. (1986). The unlabeled antibody method: Comparison ofperoxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. Journal of Histochemistry and Cytochemistry, 34, 599-605.
51. Tasch, E., Cendes, F., Li, L. M., Dubeau, F., Andermann, F., & Arnold, D. L. (1999). Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Annals of Neurology, 45, 568-576.
52. Turski, L., Cavalheiro, E. A., Czuczwar, S. J., Turski, W. A., & Kleinrok, Z. (1987). The seizures induced by pilocarpine: Behavioral, electroencephalographic and neuropathological studies in rodents. Polish Journal of Pharmacology & Pharmacy, 39, 545-555.
53. Turski, W. A., Cavalheiro, E. A., Schwarz, M., Czuczwar, S. J., Kleinrok, Z., & Turski, L. (1983). Limbic seizures produced by pilocarpine in rats: Behavioral, electroencephalographic and neuropathological study. Behavioural Brain Research, 9, 315-335.
54. Verrotti, A., Pascarella, R., Trotta, D., Giuva, T., Morgese, G., & Chiarelli, F. (2000). Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Research, 41, 253-257.
55. Westmark, C. J., Westmark, P. R., Beard, A. M., Hildebrandt, S. M., & Malter, J. S. (2008). Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. International Journal of Clinical and Experimental Pathology, 1, 157-168.
56. Yilmazer-Hanke, D. M., Wolf, H. K., Schramm, J., Elger, C. E., Wiestler, O. D., & Blumcke, I. (2000). Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy. Journal of Neuropathology and Experimental Neurology, 59, 907-920.